SteinbergMH. Sickle Cell Disease. Ann Intern Med, 2011; 155:ITC3–1.
2.
KatoGJ, GladwinMT, SteinbergMH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev, 2007; 21:37–47.
3.
LanzkronS, StrouseJJ, WilsonRet al.Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med, 2008; 148:939–955.
4.
Bolaños-MeadeJ, BrodskyRA. Blood and marrow transplantation for sickle cell disease: Overcoming barriers to success. Curr Op Oncol, 2009; 21:158–161. 10.1097/CCO.0b013e328324ba04.
5.
PlattOS, ThoringtonBD, BrambillaDJet al.Pain in sickle cell disease: Rates and risk factors. N Engl J Med, 1991; 325:11–16.
6.
BrousseauDC, PamelaLet al.Acute care utilization and rehospitalizations for sickle cell disease. JAMA, 2010; 303,13:1288–1294.
7.
DarbariDS, OnyekwereO, NouraieMet al.Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr, 2012; 160,2:286–290.
8.
ElanderJ, BeachMC, HaywoodCJr.Respect, trust, and the management of sickle cell disease pain in hospital: Comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health, 2011; 16,4–5:405–421.
9.
BallasSK. Update on pain management in sickle cell disease. Hemoglobin, 2011; 35:520–529.
10.
DunlopR, BennettKCLB. Pain management for sickle cell disease in children and adults. Cochrane Database of Systematic Reviews, 2006; 2Art. No. CD00335010.1002/14651858.CD003350.pub2.
11.
ReesDC, OlujohungbeAD, ParkerNEet al.Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol, 2003; 120:744–752.
12.
van BeersEJ, van TuijnCFJ, NieuwkerkPTet al.Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol, 2007; 82:955–960.
13.
FinkelsteinY, SchechterT, Garcia-BournissenFet al.Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. Clin Ther, 2007; 29:2738–2743.
14.
BelletPS, KalinyakKA, ShuklaRet al.Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med, 1995; 333:699–703.
15.
KjellbergF, TramèrMR. Pharmacological control of opioid-induced pruritus: A quantitative systematic review of randomized trials. Eur J Anaesthesiol, 2001; 18,6:346.
16.
TaylorLE, StottsNAet al.A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease. J Pain Symptom Manage, 2010; 40,3:416–435.
17.
SmithWR, PenberthyLT, BovbjergVEet al.Daily assessment of pain in adults with sickle cell disease. Ann Intern Med, 2008; 148:94–101.
18.
SolomonLR. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle-cell disease: an educational void. Blood, 2008; 111,3:997–1003.
19.
LusherJ, ElanderJ, BevanD, TelferP, BurtonB. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain, 2006; 22,3:316–324.
